Cardiac Thyroid Hormone Metabolism and Heart Failure

The heart is a principal target of thyroid hormone, and a reduction of cardiac thyroid hormone signaling is thought to play a role in pathological ventricular remodeling and the development of heart failure. Studies in various rodent models of heart disease have identified increased activity of cardiac type III deiodinase as a possible cause of diminished levels and action of thyroid hormone. Recent data indicate novel mechanisms underlying the induction of this thyroid hormone-degrading enzyme in the heart as well as post-transcriptional regulation of its expression by microRNAs. In addition, the relevance of diminished thyroid hormone signaling for cardiac remodeling is suggested to include miRNA-mediated effects on pathological signaling pathways. These and other recent studies are reviewed and discussed in the context of other processes and factors that have been implicated in the reduction of cardiac thyroid hormone signaling in heart failure.

• Publication year

  2017

• Venue

  European Thyroid Journal

• Publication date

  2017-04-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000469708PMID 28785539PMCID PMC5527173
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Physiology of the Normal and Failing Heart

  2017cited by this paper
• Trans Fatty Acids Suppress TNF-α-Induced Inflammatory Gene Expression in Endothelial (HUVEC) and Hepatocellular Carcinoma (HepG2) Cells

  2017cited by this paper
• MicroRNA 214 Is a Potential Regulator of Thyroid Hormone Levels in the Mouse Heart Following Myocardial Infarction, by Targeting the Thyroid-Hormone-Inactivating Enzyme Deiodinase Type III

  2016cited by this paper
• Safe Oral Triiodo-L-Thyronine Therapy Protects from Post-Infarct Cardiac Dysfunction and Arrhythmias without Cardiovascular Adverse Effects

  2016cited by this paper
• Thyroid hormones and cardiac remodeling

  2016cited by this paper
• Cardioprotection and thyroid hormones

  2016cited by this paper
• Reciprocal interplay between thyroid hormone and microRNA-21 regulates hedgehog pathway-driven skin tumorigenesis.

  2016cited by this paper
• Tissue thyroid hormones and thyronamines

  2016cited by this paper
• The molecular basis of the non-thyroidal illness syndrome.

  2015cited by this paper
• Restoration of thyroid hormone balance: a game changer in the treatment of heart failure?

  2015cited by this paper
• Thyroid hormone action in postnatal heart development.

  2014cited by this paper
• Development of microRNA therapeutics is coming of age

  2014cited by this paper
• Intracellular Inactivation of Thyroid Hormone Is a Survival Mechanism for Muscle Stem Cell Proliferation and Lineage Progression

  2014cited by this paper
• Thyroid hormones and skeletal muscle—new insights and potential implications

  2014cited by this paper
• Tissue-specific alterations in thyroid hormone homeostasis in combined Mct10 and Mct8 deficiency.

  2014cited by this paper
• Low-Dose T 3 Replacement Restores Depressed Cardiac T 3 Levels , Preserves Coronary Microvasculature and Attenuates Cardiac Dysfunction in Experimental Diabetes Mellitus

  2014cited by this paper
• Thyroid Hormone-Regulated Cardiac microRNAs are Predicted to Suppress Pathological Hypertrophic Signaling

  2014cited by this paper
• Thyroid disease and the cardiovascular system.

  2014cited by this paper
• Low-Dose T3 Replacement Restores Depressed Cardiac T3 Levels, Preserves Coronary Microvasculature and Attenuates Cardiac Dysfunction in Experimental Diabetes Mellitus

  2014cited by this paper
• Tissue-Specific Expression of Monocarboxylate Transporters during Fasting in Mice

  2014cited by this paper
• Inhibition of miR-25 Improves Cardiac Contractility in the Failing Heart

  2014cited by this paper
• Cardiac expression of deiodinase type 3 (Dio3) following myocardial infarction is associated with the induction of a pluripotency microRNA signature from the Dlk1-Dio3 genomic region.

  2013cited by this paper
• Inhibition of thyroid hormone receptor α1 impairs post-ischemic cardiac performance after myocardial infarction in mice

  2013cited by this paper
• MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy - role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation.

  2013cited by this paper
• Type 3 deiodinase and solid tumors: an intriguing pair

  2013cited by this paper
• Molecular basis of physiological heart growth: fundamental concepts and new players

  2012cited by this paper
• Mechanisms of thyroid hormone action.

  2012cited by this paper
• Longstanding Hyperthyroidism Is Associated with Normal or Enhanced Intrinsic Cardiomyocyte Function despite Decline in Global Cardiac Function

  2012cited by this paper
• Absence of myocardial thyroid hormone inactivating deiodinase results in restrictive cardiomyopathy in mice.

  2012cited by this paper
• MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles

  2012cited by this paper
• The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis

  2012cited by this paper
• MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death.

  2012cited by this paper
• Deiodinases: the balance of thyroid hormone: local impact of thyroid hormone inactivation.

  2011cited by this paper
• Transient Regenerative Potential of the Neonatal Mouse Heart

  2011cited by this paper
• Epidemiology and risk profile of heart failure

  2011cited by this paper
• Beyond low plasma T3: local thyroid hormone metabolism during inflammation and infection.

  2011cited by this paper
• MiR-224 Targets the 3′UTR of Type 1 5′-Iodothyronine Deiodinase Possibly Contributing to Tissue Hypothyroidism in Renal Cancer

  2011cited by this paper
• Left-ventricular remodeling after myocardial infarction is associated with a cardiomyocyte-specific hypothyroid condition.

  2011cited by this paper
• Thyroid Replacement Therapy and Heart Failure

  2010cited by this paper
• Activation of the Imprinted Dlk1-Dio3 Region Correlates with Pluripotency Levels of Mouse Stem Cells

  2010cited by this paper
• Up-regulation of type 2 iodothyronine deiodinase in dilated cardiomyopathy.

  2010cited by this paper
• Molecular aspects of thyroid hormone actions.

  2010cited by this paper
• New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider?

  2010cited by this paper
• Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies.

  2010cited by this paper
• MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.

  2009cited by this paper
• Large induction of type III deiodinase expression after partial hepatectomy in the regenerating mouse and rat liver.

  2009cited by this paper
• Life without thyroxine to 3,5,3'-triiodothyronine conversion: studies in mice devoid of the 5'-deiodinases.

  2009cited by this paper
• Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure.

  2008cited by this paper
• MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

  2008cited by this paper
• Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats.

  2008cited by this paper
• Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10.

  2008cited by this paper
• Cardiomyocyte-specific inactivation of thyroid hormone in pathologic ventricular hypertrophy: an adaptative response or part of the problem?

  2008cited by this paper
• Fasting-Induced Changes in the Hypothalamus–Pituitary–Thyroid Axis

  2008cited by this paper
• Thyroid hormone transport in and out of cells.

  2008cited by this paper
• Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

  2008cited by this paper
• Genomic imprinting at the mammalian Dlk1-Dio3 domain.

  2008cited by this paper
• Return to the fetal gene program protects the stressed heart: a strong hypothesis

  2007cited by this paper
• The Fuzzy Logic of Physiological Cardiac Hypertrophy

  2007cited by this paper
• Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats a time course study.

  2007cited by this paper
• Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA

  2007cited by this paper
• Gene expression from the imprinted Dio3 locus is associated with cell proliferation of cultured brown adipocytes.

  2007cited by this paper
• Adeno-associated virus-mediated expression of thyroid hormone receptor isoforms-alpha1 and -beta1 improves contractile function in pressure overload-induced cardiac hypertrophy.

  2007cited by this paper
• Time-dependent changes in the expression of thyroid hormone receptor alpha 1 in the myocardium after acute myocardial infarction: possible implications in cardiac remodelling.

  2007cited by this paper
• Spatial and temporal expression of the Grainyhead-like transcription factor family during murine development.

  2006cited by this paper
• Thyroid Hormone Stimulates Protein Synthesis in the Cardiomyocyte by Activating the Akt-mTOR and p70S6K Pathways*

  2006cited by this paper
• Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction.

  2006cited by this paper
• [Thyroid hormone and the cardiovascular system].

  2006cited by this paper
• Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure.

  2005cited by this paper
• Hypothyroidism induces type 2 iodothyronine deiodinase expression in mouse heart and testis.

  2003cited by this paper
• Identification of Monocarboxylate Transporter 8 as a Specific Thyroid Hormone Transporter*

  2003cited by this paper
• Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure.

  2002cited by this paper
• Thyroid Hormone-Regulated Cardiac Gene Expression and Cardiovascular Disease

  2002cited by this paper
• Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.

  2002cited by this paper
• Type 2 Iodothyronine Deiodinase Transgene Expression in the Mouse Heart Causes Cardiac-Specific Thyrotoxicosis**This work was supported by grants from the NIH [DK-36256 (to P.R.L.); DK-49126 and DK-53036 (to F.E.W.) and Specialized Center of Research Grant HL-52320 (to J.S.I.)].

  2001cited by this paper
• Type 2 iodothyronin deiodinase transgene expression in the mouse heart causes cardiac-specific thyrotoxicosis.

  2001cited by this paper
• Tissue-specific patterns of changes in 3,5,3'-triiodo-L-thyronine concentrations in thyroidectomized rats infused with increasing doses of the hormone. Which are the regulatory mechanisms?

  1999cited by this paper
• Thyroid hormone and the cardiovascular system.

  1997cited by this paper

• Local DIO2 Elevation Is an Adaption in Malformed Cerebrovasculature

  2025cites this paper
• Comorbidities of hypothyroidism

  2025cites this paper
• Rethinking strategies for solving thyroid dysfunction at the heart of cardiovascular disease

  2025cites this paper
• Association of Serum FT3 with Severity of Heart Failure and it’s Correlation with NT-proBNP

  2025cites this paper
• Triiodothyronine protects infarcted myocardium by reducing apoptosis and preserving mitochondria

  2025cites this paper
• Maternal high fat–high energy diet alters metabolic factors in the non‐human primate fetal heart

  2024cites this paper
• Novel Biomarkers Reveal Mismatch Between Tissue and Serum Thyroid Hormone Status in Amiodarone-Induced Hyperthyroidism

  2024cites this paper
• Myocardial complications induced by hypothyroidism in rats: effects of metformin and alpha lipoic acid

  2024cites this paper
• Exogenous Thyroxine Increases Cardiac GLUT4 Translocation in Insulin Resistant OLETF Rats.

  2024cites this paper
• A Cross-Sectional Study of Acute Coronary Syndrome and Thyroid Profile: Dissecting the Relationship to Improve Patient Care

  2024cites this paper
• Thyroid Hormone Biomonitoring: A Review on Their Metabolism and Machine-Learning Based Analysis on Effects of Endocrine Disrupting Chemicals

  2024cites this paper
• STATE OF THYROID GLAND FUNCTION IN PATIENTS ADMITTED TO CORONARY CARE UNIT

  2023cites this paper
• Thyrotoxic Cardiomyopathy: State of the Art

  2023cites this paper
• Unravelling the Interplay between Cardiac Metabolism and Heart Regeneration

  2023cites this paper
• Thyroid hormone treatment counteracts cellular phenotypical remodeling in diabetic organs

  2023cites this paper
• Preliminary Experience of Early T3 Therapy in Patients with Acute Myocardial Infarction

  2022cites this paper
• Reorganization of Metabolism during Cardiomyogenesis Implies Time-Specific Signaling Pathway Regulation

  2021cites this paper
• Detection of some hormonal and enzymatic disorders associated to experimentally iodine induced hyperthyrodism.

  2021cites this paper
• Noncanonical Thyroid Hormone Receptor α Action Mediates Arterial Vasodilation.

  2021cites this paper
• Thyroid hormones and the potential for regulating glucose metabolism in cardiomyocytes during insulin resistance and T2DM

  2021influential citation
• Selenoprotein DIO2 Is a Regulator of Mitochondrial Function, Morphology and UPRmt in Human Cardiomyocytes

  2021cites this paper
• Low triiodothyronine levels correlate with high B-type natriuretic peptide levels in patients with heart failure

  2021cites this paper
• Atrioventricular Longitudinal Mechanics Using Novel Speckle-Tracking Improved Risk Stratification Beyond Baseline Thyroid Hormone in Asymptomatic Subclinical Hypothyroidism

  2021cites this paper
• MicroRNAs and thyroid hormone action.

  2021cites this paper
• Life without thyroid hormone receptor.

  2021cites this paper
• Non-thyroidal illness syndrome and hypothyroidism in ischemic heart disease population: Systematic review and meta-analysis.

  2020cites this paper
• Hypothyroidism: Cardiovascular Endpoints of Thyroid Hormone Replacement

  2020cites this paper
• Regulation of nitric oxide production in hypothyroidism.

  2020cites this paper
• The Potential of the Novel NAD+ Supplementing Agent, SNH6, as a Therapeutic Strategy for the Treatment of Friedreich's Ataxia.

  2020cites this paper
• Thyroid Hormone Abnormalities in Myocardial Infarction

  2020cites this paper
• Modalities of Thyroid Hormone Administration and Correlates Between Blood and Tissue Levels

  2020cites this paper
• Thyroid Hormone Deiodinative Pathways in the Normal and Failing Heart

  2020cites this paper
• TH Treatment in Patients with Cardiac Disorders: General Aspects and Rationale

  2020cites this paper
• TH Metabolism and Active TH Metabolites in the Heart

  2020cites this paper
• Physiological Role of Thyroid Hormone in the Developing and Mature Heart

  2020cites this paper
• Physiological and Pathological Cardiac Remodeling in Altered Thyroid Hormone States

  2020cites this paper
• Tissue-Specific Cell Signaling

  2020cites this paper
• Key Signaling Pathways in the Cardiovascular System

  2020cites this paper
• Metabolic environment in vivo as a blueprint for differentiation and maturation of human stem cell-derived cardiomyocytes.

  2020cites this paper
• T3 Critically Affects the Mhrt/Brg1 Axis to Regulate the Cardiac MHC Switch: Role of an Epigenetic Cross-Talk

  2020cites this paper
• Thyroid hormones and modulation of diastolic function: a promising target for heart failure with preserved ejection fraction

  2020cites this paper
• Lost in the fire

  2019cites this paper
• Structure et physiologie de la thyroïde

  2019cites this paper
• Thyroid Hormone Signalling: From the Dawn of Life to the Bedside

  2019cites this paper
• Novel Insight Into the Epigenetic and Post-transcriptional Control of Cardiac Gene Expression by Thyroid Hormone

  2019cites this paper
• HYPOTHYROIDISM INCREASES EXPRESSION OF STERILE INFLAMMATION PROTEINS IN RAT HEART TISSUE.

  2019cites this paper
• Stage-dependent cardiac regeneration in Xenopus is regulated by thyroid hormone availability

  2019cites this paper
• Paradigms of Dynamic Control of Thyroid Hormone Signaling.

  2019cites this paper
• 3,5-Diiodo-l-Thyronine Increases Glucose Consumption in Cardiomyoblasts Without Affecting the Contractile Performance in Rat Heart

  2018cites this paper
• Schilddrüse und Herz

  2018cites this paper
• Thyroid hormone receptor α1 as a novel therapeutic target for tissue repair.

  2018cites this paper
• CLINICAL SIGNIFICANCE OF SOME NEW THYROID PARAMETERS

  2018cites this paper
• Association Between 3-Iodothyronamine (T1AM) Concentrations and Left Ventricular Function in Chronic Heart Failure

  2018cites this paper
• Athérosclérose : pathologies associées, prévention et traitements

  2017cites this paper
• Cardioprotective effects of metformin and alpha lipoic acid against myocardial complications induced by hypothyroidism in rats

  year unknowncites this paper